These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18635746)

  • 1. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
    Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells.
    Gavelová M; Hladíková J; Vildová L; Novotná R; Vondrácek J; Krcmár P; Machala M; Skálová L
    Chem Biol Interact; 2008 Oct; 176(1):9-18. PubMed ID: 18755171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of Carbonyl Reductase 1 Renders Development of Doxorubicin Resistance in Human Gastrointestinal Cancers.
    Matsunaga T; Kezuka C; Morikawa Y; Suzuki A; Endo S; Iguchi K; Miura T; Nishinaka T; Terada T; El-Kabbani O; Hara A; Ikari A
    Biol Pharm Bull; 2015; 38(9):1309-19. PubMed ID: 26328486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+/- mice.
    Freeland MM; Angulo J; Davis AL; Flook AM; Garcia BL; King NA; Mangibin SK; Paul KM; Prosser ME; Sata N; Bentley JL; Olson LE
    Anticancer Drugs; 2012 Jul; 23(6):584-9. PubMed ID: 22343424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
    Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
    Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J; Skarka A; Havrankova J; Wsol V
    Biochem Pharmacol; 2015 Aug; 96(3):168-78. PubMed ID: 25986883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
    Olson LE; Bedja D; Alvey SJ; Cardounel AJ; Gabrielson KL; Reeves RH
    Cancer Res; 2003 Oct; 63(20):6602-6. PubMed ID: 14583452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis.
    El-Hawari Y; Favia AD; Pilka ES; Kisiela M; Oppermann U; Martin HJ; Maser E
    Chem Biol Interact; 2009 Mar; 178(1-3):234-41. PubMed ID: 19061875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified.
    Breysse DH; Boone RM; Long CM; Merrill ME; Schaupp CM; White CC; Kavanagh TJ; Schmidt EE; Merrill GF
    Drug Metab Dispos; 2020 Mar; 48(3):187-197. PubMed ID: 31955137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase/reductase superfamily.
    Miura T; Nishinaka T; Takama M; Murakami M; Terada T
    Chem Biol Interact; 2009 Mar; 178(1-3):110-6. PubMed ID: 18983989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonyl reduction of mequindox by chicken and porcine cytosol and cloned carbonyl reductase 1.
    Tang X; Mu P; Wu J; Jiang J; Zhang C; Zheng M; Deng Y
    Drug Metab Dispos; 2012 Apr; 40(4):788-95. PubMed ID: 22266778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
    Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
    Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3.
    Staab CA; Hartmanová T; El-Hawari Y; Ebert B; Kisiela M; Wsol V; Martin HJ; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):95-103. PubMed ID: 21256830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
    Hanušová V; Boušová I; Pakostová A; Skálová L
    Xenobiotica; 2012 Jun; 42(6):571-9. PubMed ID: 22217270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the substrate-binding loop region of human monomeric carbonyl reductases in catalysis and coenzyme binding.
    Miura T; Nishinaka T; Terada T
    Life Sci; 2009 Aug; 85(7-8):303-8. PubMed ID: 19555696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Tissue Distribution of Carbonyl Reductase 1 Using Proteomic Approach With Liquid Chromatography-Tandem Mass Spectrometry.
    Hua W; Zhang H; Ryu S; Yang X; Di L
    J Pharm Sci; 2017 May; 106(5):1405-1411. PubMed ID: 28161444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids as inhibitors of human carbonyl reductase 1.
    Carlquist M; Frejd T; Gorwa-Grauslund MF
    Chem Biol Interact; 2008 Jul; 174(2):98-108. PubMed ID: 18579125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.